APOC3 ASO olezarsen lowers triglycerides; Balance trial

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Beneficial effects of GLP-1RA in patients with obesity-related HFpEF and T2D
Beneficial effects of GLP-1RA in patients with obesity-related HFpEF and T2D
ACC.24
Beneficial effects of GLP-1RA in patients with obesity-related HFpEF and T2D
- Mikhail Kosiborod, MD
Long-term improvements in daily steps with gamification and financial incentives in patients at risk for CV events
Long-term improvements in daily steps with gamification and financial incentives in patients at risk for CV events
ACC.24
Long-term improvements in daily steps with gamification and financial incentives in patients at risk for CV events
- Alexander Fanaroff, MD
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
ACC.24
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
- Akshay S. Desai, MD
Preventive PCI versus optimal medical therapy only for vulnerable plaques
Preventive PCI versus optimal medical therapy only for vulnerable plaques
ACC.24
Preventive PCI versus optimal medical therapy only for vulnerable plaques
- Marc Bonaca, MD

Promising results for APOC3 ASO in familial chylomicronemia syndrome